Adherence to a lifestyle intervention - just a question of self-efficacy? Analysis of the AgeWell.de-intervention against cognitive decline.


Journal

Alzheimer's research & therapy
ISSN: 1758-9193
Titre abrégé: Alzheimers Res Ther
Pays: England
ID NLM: 101511643

Informations de publication

Date de publication:
22 Jun 2024
Historique:
received: 01 12 2023
accepted: 12 06 2024
medline: 23 6 2024
pubmed: 23 6 2024
entrez: 22 6 2024
Statut: epublish

Résumé

Aim of this study was to detect predictors of better adherence to the AgeWell.de-intervention, a two-year randomized multi-domain lifestyle intervention against cognitive decline. Data of 317 intervention group-participants comprising a risk group for dementia (Cardiovascular Risk Factors, Ageing and Dementia (CAIDE) score of  ≥ 9; mean age 68.9 years, 49.5% women) from the AgeWell.de intervention study were analysed. Regression models with four blocks of predictors (sociodemographic, cognitive and psychosocial, lifestyle factors and chronic conditions) were run on adherence to the components of nutrition, enhancement of social and physical activity and cognitive training. Adherence to each component was operationalised by assessing the degree of goal achievement per component at up to seven time points during the intervention period, measured using a 5-point Likert scale (mean score of goal achievement). Increasing age was negatively associated with adherence, while higher education positively predicted adherence. Participants with better mental state (Montreal Cognitive Assessment (MoCA)-score > 25) at baseline and higher self-efficacy adhered better. Diabetes and cardiovascular conditions were not associated with adherence, whereas smoking negatively affected adherence. Highest education and quitting smoking in the past were the only predictors associated with all four intervention components. Results identified predictors for better and worse adherence. Particularly self-efficacy seems to be of considerable influence on adherence. This should be considered when designing future intervention trials. German Clinical Trials Register (ref. number: DRKS00013555).

Sections du résumé

BACKGROUND BACKGROUND
Aim of this study was to detect predictors of better adherence to the AgeWell.de-intervention, a two-year randomized multi-domain lifestyle intervention against cognitive decline.
METHODS METHODS
Data of 317 intervention group-participants comprising a risk group for dementia (Cardiovascular Risk Factors, Ageing and Dementia (CAIDE) score of  ≥ 9; mean age 68.9 years, 49.5% women) from the AgeWell.de intervention study were analysed. Regression models with four blocks of predictors (sociodemographic, cognitive and psychosocial, lifestyle factors and chronic conditions) were run on adherence to the components of nutrition, enhancement of social and physical activity and cognitive training. Adherence to each component was operationalised by assessing the degree of goal achievement per component at up to seven time points during the intervention period, measured using a 5-point Likert scale (mean score of goal achievement).
RESULTS RESULTS
Increasing age was negatively associated with adherence, while higher education positively predicted adherence. Participants with better mental state (Montreal Cognitive Assessment (MoCA)-score > 25) at baseline and higher self-efficacy adhered better. Diabetes and cardiovascular conditions were not associated with adherence, whereas smoking negatively affected adherence. Highest education and quitting smoking in the past were the only predictors associated with all four intervention components.
CONCLUSION CONCLUSIONS
Results identified predictors for better and worse adherence. Particularly self-efficacy seems to be of considerable influence on adherence. This should be considered when designing future intervention trials.
TRIAL REGISTRATION BACKGROUND
German Clinical Trials Register (ref. number: DRKS00013555).

Identifiants

pubmed: 38909256
doi: 10.1186/s13195-024-01499-4
pii: 10.1186/s13195-024-01499-4
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

133

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1704A, 01GL1704B, 01GL1704C, 01GL1704D, 01GL1704E, 01GL1704F

Informations de copyright

© 2024. The Author(s).

Références

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020;396:413–46.
doi: 10.1016/S0140-6736(20)30367-6
Jönsson L, Wimo A, Handels R, Johansson G, Boada M, Engelborghs S, et al. The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint. The Lancet Regional Health–Europe. 2023;29.
Röhr S, Kivipelto M, Mangialasche F, Ngandu T, Riedel-Heller SG. Multidomain interventions for risk reduction and prevention of cognitive decline and dementia: current developments. Curr Opin Psychiatry. 2022;35:285–92.
doi: 10.1097/YCO.0000000000000792 pubmed: 35703256
Blotenberg I, Hoffmann W, Thyrian RJ. Dementia in Germany: Epidemiology and Prevention Potential. Deutsches Arzteblatt International. 2023:arztebl. m2023. 0100-arztebl. m2023. 0100.
Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R, et al. The Finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER): study design and progress. Alzheimers Dement. 2013;9:657–65.
doi: 10.1016/j.jalz.2012.09.012 pubmed: 23332672
Kivipelto M, Mangialasche F, Snyder HM, Allegri R, Andrieu S, Arai H, et al. World-Wide FINGERS Network: a global approach to risk reduction and prevention of dementia. Alzheimers Dement. 2020;16:1078–94.
doi: 10.1002/alz.12123 pubmed: 32627328
Zülke A, Luck T, Pabst A, Hoffmann W, Thyrian JR, Gensichen J, et al. AgeWell. de–study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients. BMC geriatrics. 2019;19:1–14.
doi: 10.1186/s12877-019-1212-1
Zülke AE, Pabst A, Luppa M, Röhr S, Seidling H, Oey A, et al. A multidomain intervention against cognitive decline in an at-risk-population in Germany – Results from the cluster-randomized AgeWell.de-trial. Alzheimer's & Dementia (Under final review). 2023.
Wittmann F, Pabst A, Zülke A, Luppa M, Blotenberg I, Cardona I, et al. Who benefited the most? Effectiveness of a lifestyle intervention against cognitive decline in older women and men - secondary analysis of the AgeWell.de-trial. The Journal of Prevention of alzheimer's Disease (Submitted / Under Revision). 2023.
Sjösten NM, Salonoja M, Piirtola M, Vahlberg TJ, Isoaho R, Hyttinen HK, et al. A multifactorial fall prevention programme in the community-dwelling aged: predictors of adherence. Eur J Pub Health. 2007;17:464–70. https://doi.org/10.1093/eurpub/ckl272 .
doi: 10.1093/eurpub/ckl272
Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. The Lancet Neurology. 2006;5:735–41.
doi: 10.1016/S1474-4422(06)70537-3 pubmed: 16914401
Röhr S, Zülke A, Luppa M, Brettschneider C, Weißenborn M, Kühne F, et al. Recruitment and baseline characteristics of participants in the AgeWell de study—a pragmatic cluster-randomized controlled lifestyle trial against cognitive decline. Int J Environ Res Public Health. 2021;18:408.
doi: 10.3390/ijerph18020408 pubmed: 33430189 pmcid: 7825589
Coley N, Ngandu T, Lehtisalo J, Soininen H, Vellas B, Richard E, et al. Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials. Alzheimers Dement. 2019;15:729–41.
doi: 10.1016/j.jalz.2019.03.005 pubmed: 31047857
Ngandu T, Lehtisalo J, Korkki S, Solomon A, Coley N, Antikainen R, et al. The effect of adherence on cognition in a multidomain lifestyle intervention (FINGER). Alzheimers Dement. 2022;18:1325–34.
doi: 10.1002/alz.12492 pubmed: 34668644
Brauns H, Steinmann S. Educational reform in France, West-Germany and the United Kingdom: updating the CASMIN educational classification. Zuma Nachrichten. 1999;23:7–44.
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
doi: 10.1111/j.1532-5415.2005.53221.x pubmed: 15817019
O’Driscoll C, Shaikh M. Cross-cultural applicability of the Montreal Cognitive Assessment (MoCA): a systematic review. J Alzheimers Dis. 2017;58:789–801.
doi: 10.3233/JAD-161042 pubmed: 28482634
Gauggel S, Birkner B. Validity and reliability of a German version of the Geriatric Depression Scale (GDS). Zeitschrift fur Klinische Psychologie-Forschung und Praxis. 1999;28:18–27.
doi: 10.1026//0084-5345.28.1.18
Jerusalem M, Schwarzer R. Allgemeine Selbstwirksamkeitserwartung. Skalen zur Erfassung von Lehrer-und Schülermerkmalen. 1999;1:13–4.
European Commission. Health promotion and disease prevention knowledge gateway: A reference point for public health policy makers with reliable, independent and up-to date information on topics related to promotion of health and well-being. 2023.
Lubben J, Blozik E, Gillmann G, Iliffe S, von Renteln Kruse W, Beck JC, Stuck AE. Performance of an abbreviated version of the Lubben Social Network Scale among three European community-dwelling older adult populations. Gerontologist. 2006;46:503–13.
doi: 10.1093/geront/46.4.503 pubmed: 16921004
Coley N, Coniasse-Brioude D, Igier V, Fournier T, Poulain J-P, Andrieu S, ACCEPT study group Sandrine Andrieu Nicola Coley Virginie Gardette Alain Grand Valérie Igier Delphine Coniasse Brioude Maria Teresa Munoz Sastre Jean Pierre Poulain Tristan Fournier Christelle Arandjelovic Bruno Vellas Stephane Oustric Julie Subra. Disparities in the participation and adherence of older adults in lifestyle-based multidomain dementia prevention and the motivational role of perceived disease risk and intervention benefits: an observational ancillary study to a randomised controlled trial. Alzheimer's Res Ther. 2021;13:1–13.
Ross CE, Wu C-l. The links between education and health. American sociological review. 1995:719–45.
Cutler DM, Lleras-Muney A. Understanding differences in health behaviors by education. J Health Econ. 2010;29:1–28.
doi: 10.1016/j.jhealeco.2009.10.003 pubmed: 19963292
Geigl C, Loss J, Leitzmann M, Janssen C. Social factors of dietary risk behavior in older German adults: Results of a multivariable analysis. Nutrients. 2022;14:1057.
doi: 10.3390/nu14051057 pubmed: 35268032 pmcid: 8912758
Ivancevich JM, McMahon JT. Education as a moderator of goal setting effectiveness. J Vocat Behav. 1977;11:83–94.
doi: 10.1016/0001-8791(77)90019-7
Anderson-Hanley C, Arciero PJ, Barcelos N, Nimon J, Rocha T, Thurin M, Maloney M. Executive function and self-regulated exergaming adherence among older adults. Front Hum Neurosci. 2014;8:989.
doi: 10.3389/fnhum.2014.00989 pubmed: 25538608 pmcid: 4256996
Diamond A. Executive functions. Annu Rev Psychol. 2013;64:135–68.
doi: 10.1146/annurev-psych-113011-143750 pubmed: 23020641
Jerstad SJ, Boutelle KN, Ness KK, Stice E. Prospective reciprocal relations between physical activity and depression in female adolescents. J Consult Clin Psychol. 2010;78:268.
doi: 10.1037/a0018793 pubmed: 20350037 pmcid: 2847789
Rajati F, Sadeghi M, Feizi A, Sharifirad G, Hasandokht T, Mostafavi F. Self-efficacy strategies to improve exercise in patients with heart failure: A systematic review. ARYA atherosclerosis. 2014;10:319.
pubmed: 25815022 pmcid: 4354085
Warner LM, French DP. 32 Self-Efficacy Interventions. The handbook of behavior change. 2020;1:461–78.
Bruinsma J, Heger I, Loukas VS, Kassiotis T, Karanasiou G, Fotiadis DI, et al. Public Perspectives on Lifestyle-Related Behavior Change for Dementia Risk Reduction: An Exploratory Qualitative Study in The Netherlands. J Alzheimers Dis. 2023;95:1–8.
Neuvonen E, Lehtisalo J, Solomon A, Antikainen R, Havulinna S, Hänninen T, et al. Psychosocial determinants for adherence to a healthy lifestyle and intervention participation in the FINGER trial: an exploratory analysis of a randomised clinical trial. Aging Clin Exp Res. 2022;34:1793–805.
doi: 10.1007/s40520-022-02088-x pubmed: 35182352 pmcid: 9283154
Lee M-C, Wu S-FV, Lu K-C, Liu C-Y, Liang S-Y, Chuang Y-H. Effectiveness of a self‐management program in enhancing quality of life, self‐care, and self‐efficacy in patients with hemodialysis: A quasi‐experimental design. 2021;4:292–9.
Dishman RK, Motl RW, Sallis JF, Dunn AL, Birnbaum AS, Welk GJ, et al. Self-management strategies mediate self-efficacy and physical activity. Am J Prev Med. 2005;29:10–8.
doi: 10.1016/j.amepre.2005.03.012 pubmed: 15958246 pmcid: 2435261
Prestwich A, Kellar I, Parker R, MacRae S, Learmonth M, Sykes B, et al. How can self-efficacy be increased? Meta-analysis of dietary interventions. Health Psychol Rev. 2014;8:270–85.
doi: 10.1080/17437199.2013.813729 pubmed: 25053214
Turunen M, Hokkanen L, Bäckman L, Stigsdotter-Neely A, Hänninen T, Paajanen T, et al. Computer-based cognitive training for older adults: Determinants of adherence. PLoS ONE. 2019;14: e0219541.
doi: 10.1371/journal.pone.0219541 pubmed: 31291337 pmcid: 6620011
Diaz Baquero AA, Perea Bartolomé MV, Toribio-Guzmán JM, Martínez-Abad F, Parra Vidales E, Bueno Aguado Y, et al. Determinants of adherence to a “GRADIOR” computer-based cognitive training program in people with mild cognitive impairment (MCI) and mild dementia. J Clin Med. 2022;11:1714.
doi: 10.3390/jcm11061714 pubmed: 35330040 pmcid: 8955227
Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol. 2005;1:91–111.
doi: 10.1146/annurev.clinpsy.1.102803.143833 pubmed: 17716083

Auteurs

Felix G Wittmann (FG)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), Medical Faculty, University of Leipzig, Phillip-Rosenthal-Str. 55, 04103, Leipzig, Germany. felix.wittmann@medizin.uni-leipzig.de.

Alexander Pabst (A)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), Medical Faculty, University of Leipzig, Phillip-Rosenthal-Str. 55, 04103, Leipzig, Germany.

Andrea Zülke (A)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), Medical Faculty, University of Leipzig, Phillip-Rosenthal-Str. 55, 04103, Leipzig, Germany.

Melanie Luppa (M)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), Medical Faculty, University of Leipzig, Phillip-Rosenthal-Str. 55, 04103, Leipzig, Germany.

Anke Oey (A)

Institute for General Practice, Work Group Medical Statistics and IT-Infrastructure, Hannover Medical School, Hannover, Germany.

Melanie Boekholt (M)

Institute for Community Medicine, University Medicine Greifswald (UMG), Greifswald, Germany.

Solveig Weise (S)

Institute of General Practice and Family Medicine, Martin-Luther-University Halle-Wittenberg, Halle, Saale, Germany.

Thomas Fankhänel (T)

Institute of General Practice and Family Medicine, Martin-Luther-University Halle-Wittenberg, Halle, Saale, Germany.

Robert P Kosilek (RP)

Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.

Christian Brettschneider (C)

Department of Health Economics and Health Service Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Juliane Döhring (J)

Institute of General Practice, University of Kiel, Kiel, Germany.

Laura Lunden (L)

Institute of General Practice, University of Kiel, Kiel, Germany.

Birgitt Wiese (B)

Institute for General Practice, Work Group Medical Statistics and IT-Infrastructure, Hannover Medical School, Hannover, Germany.

Wolfgang Hoffmann (W)

Institute for Community Medicine, University Medicine Greifswald (UMG), Greifswald, Germany.
German Centre for Neurodegenerative Diseases (DZNE), Site Rostock/ Greifswald, Greifswald, Germany.

Thomas Frese (T)

Institute of General Practice and Family Medicine, Martin-Luther-University Halle-Wittenberg, Halle, Saale, Germany.

Jochen Gensichen (J)

Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.

Hans-Helmut König (HH)

Department of Health Economics and Health Service Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Hanna Kaduszkiewicz (H)

Institute of General Practice, University of Kiel, Kiel, Germany.

Jochen René Thyrian (JR)

Institute for Community Medicine, University Medicine Greifswald (UMG), Greifswald, Germany.
German Centre for Neurodegenerative Diseases (DZNE), Site Rostock/ Greifswald, Greifswald, Germany.
Faculty V: School of Life Sciences, University of Siegen, Siegen, Germany.

Steffi G Riedel-Heller (SG)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), Medical Faculty, University of Leipzig, Phillip-Rosenthal-Str. 55, 04103, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH